GediPNet logo

TGFB2 (transforming growth factor beta 2)

Gene
Entrez ID Entrez Gene ID - the GENE ID in NCBI Gene database.
7042
Gene nameGene Name - the full gene name approved by the HGNC.
Transforming growth factor beta 2
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
TGFB2
SynonymsGene synonyms aliases
G-TSF, LDS4, TGF-beta2
ChromosomeChromosome number
1
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
1q41
SummarySummary of gene provided in NCBI Entrez Gene.
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters` anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
SNPsSNP information provided by dbSNP.
SNP ID Visualize variation Clinical significance Consequence
rs10482810 G>C Conflicting-interpretations-of-pathogenicity, benign-likely-benign, likely-benign Non coding transcript variant, missense variant, coding sequence variant
rs11466408 C>T Conflicting-interpretations-of-pathogenicity, likely-benign Intron variant
rs387907278 C>A Pathogenic Coding sequence variant, missense variant, non coding transcript variant
rs398122884 ACAAT>- Pathogenic Coding sequence variant, frameshift variant, non coding transcript variant
rs398122885 C>A,T Pathogenic Synonymous variant, coding sequence variant, stop gained, non coding transcript variant
miRNAmiRNA information provided by mirtarbase database.
miRTarBase ID miRNA Experiments Reference
MIRT002285 hsa-miR-141-3p Immunoblot, Luciferase reporter assay, qRT-PCR 18483486
MIRT002285 hsa-miR-141-3p Flow, Luciferase reporter assay, qRT-PCR, Western blot 28115163
MIRT006058 hsa-miR-29b-3p ELISA, GFP reporter assay, qRT-PCR 21273536
MIRT006058 hsa-miR-29b-3p Luciferase reporter assay, qRT-PCR 23354167
MIRT017363 hsa-miR-335-5p Microarray 18185580
Transcription factors
Transcription factor Regulation Reference
ATF1 Activation 11776974
ATF2 Repression 1400310
USF1 Activation 11776974
USF2 Activation 11776974
USF2 Unknown 8943301
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
GO ID Ontology Definition Evidence Reference
GO:0000902 Process Cell morphogenesis IDA 15896309
GO:0001501 Process Skeletal system development ISS
GO:0001540 Function Amyloid-beta binding IDA 16227582
GO:0001654 Process Eye development IDA 15944186
GO:0001666 Process Response to hypoxia IMP 12411310
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
MIM
HGNC
e!Ensembl
Protein
UniProt ID P61812
Protein name Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)]
Protein function Transforming growth factor beta-2 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively. ; [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-2 (TGF-beta-2) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-2 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-2 (By similarity). ; Transforming growth factor beta-2: Multifunctional protein that regulates various processes such as angiogenesis and heart development (PubMed:22772371, PubMed:22772368). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains remain non-covalently linked rendering TGF-beta-2 inactive during storage in extracellular matrix (By similarity). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-2 and maintain it in a latent state during storage in extracellular milieus (By similarity). Once activated following release of LAP, TGF-beta-2 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (By similarity).
PDB 1TFG , 2TGI , 4KXZ , 5TX4 , 5TY4 , 6I9J
Family and domains

Pfam

Accession ID Position in sequence Description Type
PF00688 TGFb_propeptide
20 284
TGF-beta propeptide
Family
PF00019 TGF_beta
316 413
Transforming growth factor beta like domain
Domain
Sequence
Sequence length 414
Interactions View interactions

| © 2021, Biomedical Informatics Centre, NIRRH |
ICMR-National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Tel: +91-22-24192104, Fax No: +91-22-24139412